188 related articles for article (PubMed ID: 27470391)
21. Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer.
Chawla JP; Iyer N; Soodan KS; Sharma A; Khurana SK; Priyadarshni P
Oral Oncol; 2015 Aug; 51(8):731-7. PubMed ID: 26093389
[TBL] [Abstract][Full Text] [Related]
22. Circulating microRNAs: novel biomarkers for esophageal cancer.
Zhou SL; Wang LD
World J Gastroenterol; 2010 May; 16(19):2348-54. PubMed ID: 20480519
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs in esophageal cancer (review).
He B; Yin B; Wang B; Xia Z; Chen C; Tang J
Mol Med Rep; 2012 Sep; 6(3):459-65. PubMed ID: 22751839
[TBL] [Abstract][Full Text] [Related]
24. The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.
Bertoli G; Cava C; Castiglioni I
Scand J Clin Lab Invest Suppl; 2016; 245():S34-9. PubMed ID: 27435502
[TBL] [Abstract][Full Text] [Related]
25. The role of microRNA in esophageal squamous cell carcinoma.
Harada K; Baba Y; Ishimoto T; Shigaki H; Kosumi K; Yoshida N; Watanabe M; Baba H
J Gastroenterol; 2016 Jun; 51(6):520-30. PubMed ID: 26794004
[TBL] [Abstract][Full Text] [Related]
26. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D
Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139
[TBL] [Abstract][Full Text] [Related]
27. Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa.
von Rahden BH; Kircher S; Kafka M; Stuermer L; Reiber C; Gattenlöhner S; Germer CT; Grimm M
Cancer Biomark; 2010; 7(6):285-94. PubMed ID: 21694467
[TBL] [Abstract][Full Text] [Related]
28. Prognosis-related microRNAs in esophageal cancer.
Hong L; Han Y; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2014 Apr; 14(4):483-9. PubMed ID: 24506707
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs and esophageal squamous cell carcinoma.
Matsushima K; Isomoto H; Kohno S; Nakao K
Digestion; 2010; 82(3):138-44. PubMed ID: 20588024
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets.
Ghafouri-Fard S; Vafaee R; Shoorei H; Taheri M
Gene; 2020 Oct; 757():144937. PubMed ID: 32640300
[TBL] [Abstract][Full Text] [Related]
31. Exosomal microRNAs: A Diagnostic and Therapeutic Small Bio-molecule in Esophageal Cancer.
Shahverdi M; Darvish M
Curr Mol Med; 2023; 23(4):312-323. PubMed ID: 35319366
[TBL] [Abstract][Full Text] [Related]
32. Distinctive microRNAs in esophageal tumor: early diagnosis, prognosis judgment, and tumor treatment.
Li SQ; Chen FJ; Cao XF
Dis Esophagus; 2013 Apr; 26(3):288-98. PubMed ID: 22458808
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.
Hong L; Han Y; Yang J; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2014 Aug; 14(8):1103-11. PubMed ID: 24707835
[TBL] [Abstract][Full Text] [Related]
34. The use of imaging and biomarkers in diagnosing Barrett's esophagus and predicting the risk of neoplastic progression.
Ramzan Z; Nassri AB; Huerta S
Expert Rev Mol Diagn; 2014 Jun; 14(5):575-91. PubMed ID: 24831686
[TBL] [Abstract][Full Text] [Related]
35. Potential Predictive Role of MicroRNAs in the Neoadjuvant Treatment of Esophageal Cancer.
Vrana D; Matzenauer M; Aujesky R; Vrba R; Neoral C; Melichar B; Souček P
Anticancer Res; 2017 Feb; 37(2):403-412. PubMed ID: 28179285
[TBL] [Abstract][Full Text] [Related]
36. Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma.
Smith E; De Young NJ; Pavey SJ; Hayward NK; Nancarrow DJ; Whiteman DC; Smithers BM; Ruszkiewicz AR; Clouston AD; Gotley DC; Devitt PG; Jamieson GG; Drew PA
Mol Cancer; 2008 Oct; 7():75. PubMed ID: 18831746
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-modulated autophagic signaling networks in cancer.
Fu LL; Wen X; Bao JK; Liu B
Int J Biochem Cell Biol; 2012 May; 44(5):733-6. PubMed ID: 22342941
[TBL] [Abstract][Full Text] [Related]
38. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
39. microRNA involvement in the onset and progression of Barrett's esophagus: a systematic review.
Clark RJ; Craig MP; Agrawal S; Kadakia M
Oncotarget; 2018 Jan; 9(8):8179-8196. PubMed ID: 29487725
[TBL] [Abstract][Full Text] [Related]
40. Extracellular miRNAs for the Management of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review.
Inokuchi K; Ochiya T; Matsuzaki J
J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33396321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]